269 results on '"de la Cueva, Pablo"'
Search Results
2. Multicenter Retrospective Study of Secukinumab Drug Survival in Psoriasis Patients in a Daily Practice Setting: A Long-Term Experience in Spain
3. Patient Journey in Atopic Dermatitis: The Real-World Scenario
4. Current status of multidisciplinary care in psoriatic arthritis in Spain: NEXUS 2.0 project
5. Estado actual de la atención multidisciplinar para pacientes con artritis psoriásica en España: proyecto NEXUS 2.0
6. Dose reduction is a feasible strategy in patients with plaque psoriasis who achieve sustained response with secukinumab: a retrospective, multicenter cohort study in daily practice setting
7. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry.
8. Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
9. Epidemiological and Clinical Characteristics of Patients Admitted to a Secondary Hospital with Suspected MPOX Virus Infection: Is HIV Playing a Role?
10. Multidisciplinary Care Models for Patients With Psoriatic Arthritis
11. Modelos de atención multidisciplinar en pacientes con artritis psoriásica en España
12. Standards of care and quality indicators for multidisciplinary care models for psoriatic arthritis in Spain
13. Apremilast treatment of plaque psoriasis (PsO) after systemic therapy in Spanish clinical practice: Data from the APPROPRIATE study
14. Treatment of severe atopic dermatitis with Tralokinumab in real clinical practice. Short-term effectiveness and safety results
15. Cardiovascular Screening Practices and Statin Prescription Habits in Patients with Psoriasis among Dermatologists, Rheumatologists and Primary Care Physicians
16. Treatment of severe atopic dermatitis with tralokinumab in clinical practice: short-term effectiveness and safety results.
17. Secukinumab is effective and safe in the long‐term treatment of plaque psoriasis in a daily practice setting: Multicenter study in 384 Spanish patients
18. Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results
19. Ustekinumab to guselkumab transitions: A series of 54 patients emulating the navigate trial in real life
20. High adherence to secukinumab in patients with moderate to severe psoriasis: a long‐term multicenter study in a daily practice setting
21. Fast and sustained improvement of patient‐reported outcomes in psoriatic patients treated with secukinumab in a daily practice setting
22. [[[Translated article]]Implementation of Recommendations for the Management of Psoriasis During Preconception, Pregnancy, Postpartum, Breastfeeding, and Perinatal Care
23. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
24. Encuesta sobre el Poder Judicial
25. Los tribunales superiores de justicia. Balance de tres décadas
26. High adherence to secukinumab in patients with moderate to severe psoriasis: a long‐term multicenter study in a daily practice setting.
27. Implementación de las recomendaciones sobre las actuaciones a seguir durante la edad fértil, embarazo, postparto, lactancia y cuidado perinatal en pacientes con psoriasis
28. Effectiveness and safety of guselkumab for the treatment of psoriasis in real-world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group
29. LA COMPRENSIÓN DEL ESTADO A LA LUZ DE LA COMPARACIÓN
30. Risankizumab in psoriasis: prior biologics failure does not impact on short-term effectiveness
31. La pandemia, el estado de alarma y los jueces
32. A deletion at ADAMTS9-MAGI1 locus is associated with psoriatic arthritis risk
33. Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
34. Malignant melanoma of the breast: A case report and review of the literature: 815
35. A New Classification of the Severity of Psoriasis: What’s Moderate Psoriasis?
36. 43094 Impact and management of psoriasis in clinical practice in the Spanish National Health System: The SUMMER Project
37. Los tribunales superiores de justicia. Balance de tres décadas.
38. The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry.
39. Las garantías parlamentarias en la experiencia constitucional española
40. Recomendaciones del Grupo de Psoriasis de la AEDV sobre el manejo de la consulta de psoriasis durante la pandemia por COVID-19
41. Encuesta sobre la protección de datos personales
42. La aventura del Boletín Informativo del Seminario de Derecho Político de la Universidad de Salamanca (1954/1964).
43. Encuesta sobre la Protección de Datos Personales
44. Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis
45. Encuesta sobre la Protección de Datos Personales
46. La aventura del Boletín Informativo del Seminario de Derecho Político de la Universidad de Salamanca (1954/1964).
47. Erythrodermic psoriasis successfully treated with ustekinumab: P6328
48. General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach
49. Experience in patients with hidradenitis suppurativa and COVID-19 symptoms
50. Long-term safety of nine systemic medications for psoriasis: A cohort study using the Spanish Registry of Adverse Events for Biological Therapy in Dermatological Diseases (BIOBADADERM) Registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.